Ftse Mib
33.235,42
-0,24%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.051,07
-0,13%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nexalin Technologies Inc (NXL) Nexalin Technologies Inc (NXL) Notizie

Nexalin Technologies Inc

NXL
1,56
0,8051 (106,65%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/6/202421:00GLOBENexalin Technology Announces Regulatory Approval to Sell..
04/6/202414:30GLOBENexalin Technology to Present at the Spring MicroCap Rodeo..
03/6/202414:30GLOBEFDA Provides Feedback and Reaches Consensus on Nexalin’s..
22/5/202414:30GLOBENexalin America Selected to Join the National Traumatic..
09/5/202414:30GLOBEJoin Nexalin Technology’s Exclusive Live Investor Webinar..
25/4/202416:44GLOBENexalin Technology Regains Compliance with Nasdaq Continued..
09/4/202414:30GLOBENexalin Technology Accelerates Manufacturing of its HALO™..
04/4/202419:00GLOBENexalin Technology Awarded Key Patent Related to its Gen-3..
02/4/202414:30GLOBENexalin Technology Announces the Appointment of Government..
28/3/202413:30GLOBENexalin Technology Announces Positive Results of Clinical..
14/3/202413:30GLOBENexalin Technology Commences Sales of Gen-2 Neurostimulation..
13/3/202413:30GLOBENexalin Technology Announces Poster Presentation at “State..
08/2/202414:30GLOBENexalin Technology Announces Regulatory Approval in Oman for..
23/1/202414:30GLOBENexalin Technology Awarded Key Patent Related to its..
11/1/202414:30GLOBENexalin Technology Unveils Next-Generation HALO™ Clarity
18/12/202314:30GLOBENexalin Technology Reports Significant Positive Results of..
13/11/202322:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202320:38EDGAR2Form 8-K - Current report
25/10/202314:30GLOBENexalin Technology Announces Formation of New Military &..
16/10/202314:30GLOBENexalin Technology Announces Publication of Groundbreaking..
05/10/202318:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202322:18EDGAR2Form 8-K - Current report
10/8/202321:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202314:30GLOBENexalin Technology Reports Results of Clinical Study..
03/8/202314:30GLOBENexalin’s CEO Mark White to be Interviewed Live on “The Big..
26/7/202314:30GLOBENexalin Technology Announces New Public Sector Division to..
10/7/202314:30GLOBENexalin Technology Announces Abstract Accepted for..
30/6/202321:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
Apertura: 0,7323 Min: 0,71 Max: 1,20
Chiusura: 0,7549

La tua Cronologia

NASDAQ
NXL
Nexalin Technologies
BIT
P1YWC1
NLBNPIT1YWC1 20351221 34...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network